Nutrient-dense drink
Dietary Supplementa nutrient-dense drink developed by FrieslandCampina in line with the European Society for Clinical Nutrition and Metabolism guidelines for the dietary management of older malnourished patients
NCT Number: NCT06068816
The primary outcome is the mean difference in energy and protein as well as a selection of micronutrients (calcium, vitamin D, and Vitamin B12) after 12 weeks of intervention between standard care plus nutritional supplementation vs standard care.
The secondary outcomes are body weight, nutritional status, body composition, physical performance, vitamin D level, and nonelective hospitalization
The Study Hypothesize:
The hypothesize that outpatients who receive nutrient-dense drinks (NDD) will have increased body weight, better nutritional status, better body composition, higher vitamin D level, better physical performance and reduced non-elective hospitalization than those receiving standard care after 12 weeks of intervention.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Cipto Mangunkusumo National Hospital, Jakarta, Indonesia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a nutrient-dense drink developed by FrieslandCampina in line with the European Society for Clinical Nutrition and Metabolism guidelines for the dietary management of older malnourished patients
Time frame: at baseline and week 12
Dietary intake will be measured using 3-day dietary food records, 2 weekdays and 1 weekend day)
Time frame: at baseline and week 12
Dietary intake will be measured using 3-day dietary food records, 2 weekdays and 1 weekend day)
Time frame: at baseline and week 12
Dietary intake will be measured using 3-day dietary food records, 2 weekdays and 1 weekend day)
Time frame: at baseline and week 12
Dietary intake will be measured using 3-day dietary food records, 2 weekdays and 1 weekend day)
Time frame: at baseline and week 12
Dietary intake will be measured using 3-day dietary food records, 2 weekdays and 1 weekend day)
Time frame: at screening (Week 0) and week 12
The nutritional status will be measured by full form mini nutritional assessment, individuals can be divided in 3 groups using threshold values of <17 for malnourished, 17-23,5 for at risk of malnutrition and ≥ 24 for normal nutritional status with a maximum total score of 30 points
Time frame: Screening (Week 0) and week 12
Vitamin D level as a parameter of nutritional status will be measured by the direct competitive chemiluminescence microparticle immunoassay (CMIA) method
Time frame: Screening (week 0) and Week 12
Body weight will be measured in the fasted state to the nearest 0.1 kg with a calibrated digital scale
Time frame: Screening (Week 0) and week 12
Skeletal Muscle mass will be measured by Bioelectrical Impedance Analysis (BIA) recorded in Kg
Time frame: Screening (Week 0) and week 12
Physical performance will be measured by Short Physical Performance Battery, which is measured by scores from Gait speed, chair stand test, and balance test
Scoring for complete Short Physical Performance Battery
Category Scores :
0 - 6 points : poor performance 7-9 points : moderate performance 10-12 points : good performances
Time frame: Screening (Week 0) and week 12
Handgrip strength will be measured by a handgrip dynamometer (recorded in Kg)
Time frame: 3 months (12 weeks)
Non-elective hospitalization will be recorded by medical history
Time frame: Screening (Week 0) and week 12
Outcome recorded in seconds for Baseline, and the Changes (Delta) in 12 weeks
Additionally, results will be converted into score, which will be used for final SPPB scoring
3 meter walk: The score is, If time is more than 6''52 sec : 1 point If time is 4"66 to 6"52 sec : 2 points If time is 3"62 to 4"65 sec: 3 points If time is less than 3"62 sec:4 points
Time frame: Screening (Week 0) and week 12
Outcome recorded in seconds for Baseline, and the Changes (Delta) in 12 weeks
Additionally, results will be converted into score, which will be used for final SPPB scoring
Participant unable to complete 5 chair stands or completes stands in >60 sec : 0 points If chair stand time is 16"70 sec or more: 1 points If chair stand time is 13"70 to 16"69 sec: 2 points If chair stand time is 11"20 to 13"69 sec: 3 points If chair stand time is 11"19 sec or less: 4 points
Score will be used for final SPPB scoring
Time frame: Screening (Week 0) and week 12
Outcome recorded in seconds
A. Side-by-side-stand
Held for 10 sec ❒ 1 point If participant did not attempt test or failed, circle why:
Not held for 10 sec ❒ 0 points Tried but unable 1 Not attempted ❒ 0 points Participant could not hold position unassisted 2 If 0 points, end Balance Tests Number of seconds held if instructions less than 10 sec: . sec
B. Semi-Tandem Stand Held for 10 sec ❒ 1 point Not held for 10 sec ❒ 0 points Not attempted ❒ 0 points (circle reason above) If 0 points, end Balance Tests Number of seconds held if less than 10 sec: . sec
C. Tandem Stand Held for 10 sec ❒ 2 points Held for 3 to 9.99 sec ❒ 1 point Held for < than 3 sec ❒ 0 points Not attempted ❒ 0 points (circle reason above) Number of seconds held if less than 10 sec: . sec
Not reported as Secondary outcome but results will be used to calculate SPPB score
Indonesia University
Other
The Effect of 12 Weeks of Nutritional Supplementation on Nutritional Intake and Status in Older Outpatients With Malnutrition Risk
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02911246
Brain Diseases, Brain Injuries
Nantes, France
View Trial DetailsNCT06397118
Anemia, Anemia, Hemolytic
Nashville, Tennessee, United States
View Trial DetailsNCT04244851
Malnutrition, Nutrition Disorders
Rennes, France
View Trial DetailsNCT07620197
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kisumu, Kenya
View Trial Details